K. M. Stewart, K. L. Horton, and S. O. Kelley, Cell-penetrating peptides as delivery vehicles for biology and medicine, Organic & Biomolecular Chemistry, vol.14, issue.13, pp.2242-2255, 2008.
DOI : 10.1039/b719950c

S. Aroui, N. Ram, F. Appaix, M. Ronjat, A. Kenani et al., Maurocalcine as a Non Toxic Drug Carrier Overcomes Doxorubicin Resistance in the Cancer Cell Line MDA-MB 231, Pharmaceutical Research, vol.106, issue.Pt 4, pp.11095-11103, 2008.
DOI : 10.1007/s11095-008-9782-1
URL : https://hal.archives-ouvertes.fr/inserm-00356481

S. Elmore, Apoptosis: A Review of Programmed Cell Death, Toxicologic Pathology, vol.135, issue.2, pp.495-516, 2007.
DOI : 10.1016/S0092-8674(00)81382-3

M. O. Hengartner, The biochemistry of apoptosis, Nature, vol.407, issue.6805, pp.770-776, 2000.
DOI : 10.1038/35037710

G. M. Cohen, Caspases: the executioners of apoptosis, Biochemical Journal, vol.326, issue.1, pp.1-16, 1997.
DOI : 10.1042/bj3260001

G. Salvesen and V. M. Dixit, Caspases: Intracellular Signaling by Proteolysis, Cell, vol.91, issue.4, pp.443-446, 1997.
DOI : 10.1016/S0092-8674(00)80430-4
URL : http://doi.org/10.1016/s0092-8674(00)80430-4

W. C. Earnshaw, Nuclear changes in apoptosis, Current Opinion in Cell Biology, vol.7, issue.3, pp.337-343, 1995.
DOI : 10.1016/0955-0674(95)80088-3

D. R. Green and J. C. Reed, Mitochondria and Apoptosis, Science, vol.281, issue.5381, pp.1309-1312, 1998.
DOI : 10.1126/science.281.5381.1309

G. Minotti, P. Menna, E. Salvatorelli, G. Cairo, and L. Gianni, Anthracyclines: Molecular Advances and Pharmacologic Developments in Antitumor Activity and Cardiotoxicity, Pharmacological Reviews, vol.56, issue.2, pp.56-185, 2004.
DOI : 10.1124/pr.56.2.6

D. A. Gewirtz, A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics adriamycin and daunorubicin, Biochemical Pharmacology, vol.57, issue.7, pp.727-741, 1999.
DOI : 10.1016/S0006-2952(98)00307-4

S. Gamen, A. Anel, P. Perez-galan, P. Lasierra, D. Johnson et al., Doxorubicin treatment activates a Z-VAD-sensitive caspase, which causes deltapsim loss, caspase-9 activity, and apoptosis in Jurkat cells, Exp. Cell. Res, pp.258-223, 2000.

Y. A. Hannun, Apoptosis and the dilemma of cancer chemotherapy, Blood, vol.89, pp.1845-1853, 1997.

M. Los, I. Herr, C. Friesen, S. Fulda, K. Schulze-osthoff et al., Cross-resistance of CD95 and drug-induced apoptosis as a consequence of deficient activation of caspases (ICE/Ced-3 proteases), Blood, vol.90, pp.3118-3129, 1997.

]. Y. Wang, G. Blandino, and D. , Induced p21waf expression in H1299 cell line promotes cell senescence and protects against cytotoxic effect of radiation and doxorubicin, Oncogene, vol.18, issue.16, pp.2643-2649, 1999.
DOI : 10.1038/sj.onc.1202632

E. Young-woo, K. Mi-ae, S. P. Seok, J. G. Mi, J. K. Hyuk et al., Two distinct modes of cell death induced by doxorubicin: apoptosis and cell death through mitotic catastrophe accompanied by senescence-like phenotype, Oncogene, vol.24, pp.4765-4777, 2005.

M. M. Keane, S. A. Ettenberg, M. M. Nau, E. K. Russell, and S. Lipkowitz, Chemotherapy augments TRAIL-induced apoptosis in breast cell lines, Cancer Res, pp.59-734, 1999.

Y. Muzutani, O. Yoshida, T. Miki, and B. Bonavida, Synergistic cytotoxicity and apoptosis by Apo-2 ligand and adriamycin against bladder cancer cells, Clin. Cancer Res, vol.5, pp.2605-2612, 1999.

T. Yamanaka, K. Shiraki, and K. Sugimoto, Chemotherapeutic Agents Augment TRAIL-Induced Apoptosis in Human Hepatocellular Carcinoma Cell Lines, Hepatology, vol.6, issue.3, pp.482-490, 2000.
DOI : 10.1053/jhep.2000.16266

S. Lacour, A. Hammann, A. Wotawa, L. Corcos, E. Solary et al., Anticancer agents sensitize tumor cells to tumor necrosis factor-related apoptosis-inducing ligand-mediated caspase- 8 activation and apoptosis, Cancer Res, pp.61-1645, 2001.

D. Trisciuoglio, B. Uranchimeg, J. H. Cardellina, T. L. Meragelman, S. Matsunaga et al., Induction of Apoptosis in Human Cancer Cells by Candidaspongiolide, a Novel Sponge Polyketide, JNCI Journal of the National Cancer Institute, vol.100, issue.17, pp.1233-1246, 2008.
DOI : 10.1093/jnci/djn239

S. Brahim, L. Prevotat, S. Yatouji, D. Merino, M. Cortier et al., Deglycosylated bleomycin induces apoptosis in lymphoma cell via c-jun NH2-terminal kinase but not reactive oxygen species, Biochem. Phar, pp.74-1445, 2007.

W. Davis, Z. Ronai, and K. D. Tew, Cellular thiols and reactive oxygen species in drug-induced apoptosis, J. Pharmacol. Exp. Ther, pp.296-297, 2001.

C. Fleury, B. Mignotte, and J. L. Vayssiere, Mitochondrial reactive oxygen species in cell death signalling, Biochimie, vol.84, pp.31-141, 2002.

D. M. Hockenbery, C. D. Giedt, J. W. O-'neill, M. K. Manion, and D. E. Banker, Mitochondria and apoptosis: New therapeutic targets, Adv. Cancer Res, vol.85, pp.3-242, 2002.
DOI : 10.1016/S0065-230X(02)85007-2

J. Henry-mowatt, C. Dive, J. C. Martinou, and D. James, Role of mitochondrial membrane permeabilization in apoptosis and cancer, Oncogene, vol.23, issue.16, pp.2850-2860, 2004.
DOI : 10.1038/sj.onc.1207534

J. D. Ly, D. R. Grubb, and A. Lawen, The mitochondrial membrane potential (Ym) in apoptosis; an update, APOPTOSIS, vol.8, issue.2, pp.115-128, 2003.
DOI : 10.1023/A:1022945107762

T. Kuwana and D. D. Newmeyer, Bcl-2-family proteins and the role of mitochondria in apoptosis, Current Opinion in Cell Biology, vol.15, issue.6, pp.691-699, 2003.
DOI : 10.1016/j.ceb.2003.10.004

L. Scorrano and S. J. Korsmeyer, Mechanisms of cytochrome c release by proapoptotic BCL-2 family members, Biochemical and Biophysical Research Communications, vol.304, issue.3, pp.437-444, 2003.
DOI : 10.1016/S0006-291X(03)00615-6

A. Ferreira, L. A. Matsubara, and L. S. Matsubara, Anthracycline-Induced Cardiotoxicity, Cardiovascular & Hematological Agents in Medicinal Chemistry, vol.6, issue.4, pp.278-281, 2008.
DOI : 10.2174/187152508785909474

P. H. Viale and D. S. Yamamoto, Cardiovascular Toxicity Associated With Cancer Treatment, Clinical Journal of Oncology Nursing, vol.12, issue.4, pp.627-638, 2008.
DOI : 10.1188/08.CJON.627-638

D. Karunagaran, J. Joseph, and T. R. Kumar, CELL GROWTH REGULATION, Adv. Exp. Med. Biol, vol.595, pp.245-268, 2007.
DOI : 10.1007/978-0-387-46401-5_11

G. Takemura and H. Fujiwara, Doxorubicin-Induced Cardiomyopathy, Progress in Cardiovascular Diseases, vol.49, issue.5, pp.330-352, 2007.
DOI : 10.1016/j.pcad.2006.10.002